Logo image of ELVN

ENLIVEN THERAPEUTICS INC (ELVN) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:ELVN - US29337E1029 - Common Stock

21.75 USD
+0.48 (+2.26%)
Last: 11/21/2025, 8:25:05 PM
21.75 USD
0 (0%)
After Hours: 11/21/2025, 8:25:05 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to ELVN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 41.48. This target is 90.71% above the current price.
ELVN was analyzed by 16 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ELVN.
In the previous month the buy percentage consensus was at a similar level.
ELVN was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
ELVN Historical Analyst RatingsELVN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -36 -33 -30 -27 -24 -21 -18 -15 -12 -9 -6 -3 0 5 10 15

Price Target & Forecast

Price Low Median Mean High 21.7533.3338.7641.4854.60 - 53.24% 78.21% 90.71% 151.03%
ELVN Current Analyst RatingELVN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-07-02 HC Wainwright & Co. Maintains Buy -> Buy
2025-06-16 Baird Maintains Outperform -> Outperform
2025-06-16 Goldman Sachs Initiate Buy
2025-05-16 Jones Trading Maintains Buy -> Buy
2025-05-15 HC Wainwright & Co. Maintains Buy -> Buy
2025-03-21 HC Wainwright & Co. Maintains Buy -> Buy
2024-12-13 BTIG Initiate Buy
2024-11-15 Baird Maintains Outperform -> Outperform
2024-10-31 Jones Trading Initiate Buy
2024-10-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-09 HC Wainwright & Co. Initiate Buy
2024-06-11 Baird Initiate Outperform
2024-04-09 Mizuho Initiate Buy
2023-03-29 Jefferies Initiate Buy
2023-03-03 TD Cowen Initiate Outperform

ENLIVEN THERAPEUTICS INC / ELVN FAQ

What is the price target for ELVN stock?

16 analysts have analysed ELVN and the average price target is 41.48 USD. This implies a price increase of 90.71% is expected in the next year compared to the current price of 21.75.


How do analysts rate ENLIVEN THERAPEUTICS INC (ELVN)?

The consensus rating for ENLIVEN THERAPEUTICS INC (ELVN) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.